HIV-1 entry inhibitors: evading the issue.
Michael
N L
NL
Moore
J P
JP
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology*; D015195:Drug Design; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008954:Models, Biological; D019713:Receptors, CCR5 / Q000502:physiology; D019718:Receptors, CXCR4 / Q000502:physiology
D019380:Anti-HIV Agents; D019713:Receptors, CCR5; D019718:Receptors, CXCR4